621 Chemical Engineering in Cancer Therapy

Thursday, November 1, 2012: 8:30 AM
Somerset West (Westin )
Description:
To be filled in by Neil Forbes

Sponsor:
Engineering Fundamentals in Life Science
Co-Sponsor(s):
Biomedical Applications of Chemical Engineering (T7)

Chair:
Neil S. Forbes
Email: forbes@ecs.umass.edu


8:30 AM
(621a) Development of Three-Dimensional Lung Multicellular Spheroids in Air and Liquid Interface Culture for the Evaluation of Anti-Cancer Therapeutics
Samantha A. Meenach, Alexandra N. Tsoras, Ronald C. McGarry, Heidi M. Mansour, J. Zach Hilt and Kimberly W. Anderson

8:48 AM
(621b) Treatment Tests of Breast Cancer in Mice Using a Vascular-Targeted Enzyme Prodrug Therapy
Brent D. Van Rite, Vassilios I. Sikavitsas, Mohamad Cherry, Carla Kurkjian and Roger G. Harrison

9:24 AM
(621d) Inferring Tumor-Immune Interaction Networks Via Unbiased Secretome Profiling
Yogesh Kulkarni, Kisheon Alexander, Yueting Wu and David J. Klinke

10:00 AM
(621f) Mechanistic Investigation of the TRAIL-Sensitization Activity of Mitoxantrone
David J. Taylor, Taraka Sai Pavan Grandhi, Arul Jayaraman and Kaushal Rege

10:18 AM
(621g) Differential Effects of Chemokines and Growth Factors On Tumor Cell Migration Using a 3D Microfluidic in Vitro Model
Beum Jun Kim, Pimkhuan Hannanta-anan, Yoon Soo Kim, Michelle Chau, Melody A. Swartz and Mingming Wu